13F filer · CIK 1595855
Opaleye Management Inc.
BOSTON, MA · filing since Q4 2013 · last filing Aug 14, 2026
Reported value
$1.1B
+$345.0M vs prior
Positions
58
New / sold out
13 / 9
Added / reduced
15 / 13
Turnover
10.5%
buys $156.7M · sells $98.0M
Top-10 weight
64.8%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Added | DISC MEDICINE INC | +434,000 | +103.1% | +$31.7M |
| New | IMMIX BIOPHARMA INC | +2,345,000 | – | +$24.2M |
| Added | MEIRAGTX HLDGS PLC | +1,426,741 | +67.2% | +$19.3M |
| New | MONTE ROSA THERAPEUTICS INC | +745,000 | – | +$18.0M |
| New | REPLIMUNE GROUP INC | +1,384,993 | – | +$15.3M |
| Added | CABALETTA BIO INC | +2,483,800 | +180.0% | +$7.7M |
| New | VERASTEM INC | +1,800,000 | – | +$6.9M |
| Added | EDITAS MEDICINE INC | +1,934,933 | +100.4% | +$6.3M |
| Added | BRIDGEBIO ONCOLOGY THERAPEUT | +646,718 | +1213.8% | +$4.9M |
| Added | LYELL IMMUNOPHARMA INC | +264,928 | +334.9% | +$3.7M |
18 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | PERSPECTIVE THERAPEUTICS INC | -4,675,000 | -100.0% | $-19.5M |
| Reduced | HARROW INC | -432,230 | -15.3% | $-18.4M |
| Reduced | LIQUIDIA CORPORATION | -97,500 | -3.8% | $-7.8M |
| Reduced | SANUWAVE HEALTH INC | -675,127 | -68.8% | $-6.8M |
| Reduced | JADE BIOSCIENCES INC | -282,608 | -66.1% | $-6.3M |
| Reduced | CG ONCOLOGY INC | -77,011 | -81.2% | $-5.5M |
| Sold out | ASSERTIO HOLDINGS INC | -265,707 | -100.0% | $-5.1M |
| Sold out | SUTRO BIOPHARMA INC | -190,671 | -100.0% | $-4.7M |
| Reduced | JOURNEY MED CORP | -610,000 | -63.5% | $-4.3M |
| Reduced | Q32 BIO INC | -325,228 | -25.9% | $-4.1M |
12 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | LIQUIDIA CORPORATIONCOM NEW | 2,447,500 | $195.1M | 17.67% |
| 2 | ETON PHARMACEUTICALS INCCOM | 2,860,000 | $103.5M | 9.38% |
| 3 | HARROW INCCOM | 2,400,000 | $101.9M | 9.23% |
| 4 | DISC MEDICINE INCCOM | 855,000 | $62.5M | 5.66% |
| 5 | UROGEN PHARMA LTDCOM | 1,439,996 | $53.0M | 4.80% |
| 6 | APOGEE THERAPEUTICS INCCOM | 390,000 | $51.8M | 4.69% |
| 7 | MEIRAGTX HLDGS PLCCOM | 3,550,000 | $48.0M | 4.34% |
| 8 | SOL-GEL TECHNOLOGIES LTDSHS NEW | 500,000 | $37.1M | 3.36% |
| 9 | REZOLUTE INCCOM NEW | 6,300,000 | $32.8M | 2.97% |
| 10 | TG THERAPEUTICS INCCOM | 535,000 | $29.4M | 2.66% |
48 more rows. Subscribe for $29/month to see every row, download the data and use the API.